EAM
NTLA icon

Erste Asset Management’s Intellia Therapeutics NTLA Stock Holding History

Erste Asset Management’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-23,100
Closed -$391K – 648
2025
Q3 		$391K Sell
23,100
-62,000
-73% -$764K ﹤0.01% 506
2025
Q2 		$814K Buy
85,100
+63,000
+285% +$517K 0.01% 542
2025
Q1 		$178K Hold
22,100
– – ﹤0.01% 479
2024
Q4 		$265K Hold
22,100
– – ﹤0.01% 477
2024
Q3 		$464K Hold
22,100
– – 0.01% 442
2024
Q2 		$512K Hold
22,100
– – 0.01% 418
2024
Q1 		$597K Hold
22,100
– – 0.01% 409
2023
Q4 		$702K Hold
22,100
– – 0.01% 405
2023
Q3 		$702K Hold
22,100
– – 0.01% 375
2023
Q2 		$904K Hold
22,100
– – 0.02% 371
2023
Q1 		$796K Hold
22,100
– – 0.02% 391
2022
Q4 		$780K Sell
22,100
-45
-0.2% -$2.14K 0.02% 385
2022
Q3 		$1.22M Hold
22,145
– – 0.03% 329
2022
Q2 		$1.16M Buy
22,145
+5,800
+35% +$295K 0.03% 338
2022
Q1 		$1.18M Buy
16,345
+6,500
+66% +$551K 0.02% 341
2021
Q4 		$1.17M Buy
9,845
+45
+0.5% +$5.64K 0.02% 343
2021
Q3 		$1.35M Hold
9,800
– – 0.03% 310
2021
Q2 		$1.49M Hold
9,800
– – 0.03% 318
2021
Q1 		$708K Sell
9,800
-7,800
-44% -$524K 0.02% 358
2020
Q4 		$961K Buy
+17,600
New +$639K 0.03% 340
2019
Q1 		– Sell
-14,000
Closed -$172K – 431
2018
Q4 		$172K Buy
+14,000
New +$260K 0.01% 377

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $177M AUM 9.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Erste Asset Management's NTLA Position: Q4 2025 in Review

Erste Asset Management sold out of Intellia Therapeutics (NTLA) in Q4 2025, closing a stake of 23,100 shares — an estimated $391K sold.

Erste Asset Management first reported a position in NTLA in Q4 2018 and held it in 21 quarters. The position peaked at $1.49M in Q2 2021. 292 funds tracked by Wall St. Rank hold NTLA as of Q4 2025.

  • Erste Asset Management reported no remaining Intellia Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Erste Asset Management sold 23,100 Intellia Therapeutics shares in Q4 2025, an estimated $391K.
  • Erste Asset Management first reported a position in Intellia Therapeutics in Q4 2018 and held it in 21 quarters.
  • Erste Asset Management's Intellia Therapeutics position peaked at $1.49M in Q2 2021.
  • 292 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q4 2025.

Based on Erste Asset Management's 13F filing for Q4 2025, filed 11 Feb 2026.